Related Experiment Video
Updated: Jun 22, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Vitamin E does not regress hypercholesterolemic atherosclerosis
1Department of Physiology, University of Saskatchewan, Saskatoon, Canada. k.prasad@usask.ca
Insights
Vitamin E did not regress hypercholesterolemic atherosclerosis in rabbits. A regular diet after high cholesterol intake reduced oxidative stress but did not reverse atherosclerosis, and vitamin E accelerated it.
Area of Science:
- Cardiovascular Research
- Nutritional Science
- Oxidative Stress Studies
Background:
- Vitamin E's role in hypercholesterolemic atherosclerosis is linked to oxidative stress reduction, not serum lipid changes.
- Previous observations suggest a potential for vitamin E in managing atherosclerosis, warranting further investigation.
Purpose of the Study:
- To investigate if vitamin E can induce regression of hypercholesterolemic atherosclerosis.
- To determine if atherosclerosis regression correlates with reduced serum lipids and aortic oxidative stress.
Main Methods:
- Rabbits were fed a cholesterol-rich diet, followed by either a regular diet or a regular diet supplemented with vitamin E.
- Serum lipids and white blood cell chemiluminescence (WBC-CL) were measured monthly.
- Aortic atherosclerotic lesions, malondialdehyde (MDA), and chemiluminescence were assessed.
Main Results:
- High cholesterol diet increased serum lipids, oxidative stress, and atherosclerosis.
- While serum lipids decreased on a regular diet (with or without vitamin E), atherosclerotic lesions significantly increased.
- Vitamin E supplementation did not prevent the acceleration of atherosclerosis.
Conclusions:
- A regular diet post-cholesterol intake reduced oxidative stress but failed to induce atherosclerosis regression.
- Vitamin E did not demonstrate regression capabilities for established atherosclerosis in this model.
- Vitamin E combined with a regular diet accelerated atherosclerosis, despite no increase in oxidative stress.
Background:
Suppression of hypercholesterolemic atherosclerosis with vitamin E is associated with reductions in oxidative stress without reductions in serum lipids. The objectives of this study were to determine if (1) vitamin E regresses hypercholesterolemic atherosclerosis; and (2) regression is associated with reductions in serum lipids and aortic oxidative stress.
Methods And Results:
The studies were conducted in 4 groups of rabbits: group I, control, regular diet (2 months); group II, 0.25% cholesterol diet (2 months); group III, 0.25% cholesterol diet (2 months) followed by regular diet (2 months); and group IV, 0.25% cholesterol diet (2 months) followed by regular diet with vitamin E (40 mg/kg body weight/day) (2 months). Blood samples were collected monthly for the measurement of serum lipids and oxidative stress (chemiluminescent activity of white blood cells [WBC-CL]). Aortas were removed at the end of the protocol for assessment of atherosclerotic lesions, and oxidative stress (malondialdehyde [MDA] and CL). Increases in serum lipids in group II were associated with an increase in oxidative stress and development of atherosclerosis. Serum lipids decreased to a similar extent in groups III and IV but the atherosclerotic lesions increased by 63% and 141% compared to group II. Acceleration of atherosclerosis in the rabbits on regular diet with or without vitamin E was associated with practically no change in the oxidative stress.
Conclusion:
These results suggest that (1) regular diet following a high-cholesterol diet decreased oxidative stress but did not induce regression of atherosclerosis; (2) vitamin E did not produce regression; and (3) regular diet with vitamin E following a high-cholesterol diet was not associated with an increase in oxidative stress but produced acceleration of atherosclerosis.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis IV: Nursing Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Lipid-Lowering Drugs: Statins and Miscellaneous Agents